Comments
KiviHealth, a technology platform that aims to create next-generation medical clinic using intelligence and automation, has raised $400,000 in pre-Series A round from Chandigarh Angels Network and Claris Capital, a wholly owned subsidiary of Ahmedabad-based pharma company Claris Lifesciences.
Prior to this, the company had raised raised $130,000 in an angel round from various individual investors and healthcare experts, including Pradeep Jaisingh, founder of cancer centre network International Oncology and incubator HealthStart.
The team
Founded in 2015, KiviHealth is a doctor-patient collaboration tool that uses chatbots and visual tools to improve the combined engagement.
Bhanu Mahajan, one of the co-founders, is a medical and MBA graduate, who was working in the strategy team at Max Healthcare. The other, Rajandeep Singh, has previously worked with Microsoft and Capillary Technologies, in various technology roles.
Proven market
Krishna Handa, founder of Claris Capital, told BusinessLine : “We have observed the growth of the company over the past one year and are enthusiastic to offer our full support to the further growth of the company. We believe the company has proven its product market fit and holds a strong position at a very right time in further penetrating the ripe digital healthcare ecosystem in India.”
Vision
Hemant Sood, a participating investor from Chandigarh Angels Network, said the funds will be used to strengthen KiviHealth’s product offering and scale up sales operations.
The amount will be also used for adding new technologies, including IoT, to make the offering more inclusive for both patients and doctors.
The firm is currently operational in Maharashtra, Gujarat and Rajasthan, with more than 2,000 paying subscribers — doctors in this case — and more than one million registered patients.
Comments
COMMENT NOW
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.